NUPLAZID
- Product NDC
- 63090-340
- 11-digit product format
- 630900340
- Labeler code
- 63090
- Product ID
- 63090-340_eccfc06d-c43d-45d6-b172-414f8de9865a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pimavanserin tartrate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Acadia Pharmaceuticals Inc.
- Application
- NDA210793
- Marketing category
- NDA
- Marketing start
- 2018-06-28
- Substance
- PIMAVANSERIN TARTRATE
- Active strength
- 34 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NUPLAZID
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PIMAVANSERIN TARTRATE | 34 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | NA83F1SJSR |
| Rxcui | 2049269, 2049271, 2049275, 2049278 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63090-340-30 | NUPLAZID | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | | 22 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63090-340 | NUPLAZID (PIMAVANSERIN TARTRATE) CAPSULE NUPLAZID (PIMAVANSERIN TARTRATE) TABLET, COATED [ACADIA PHARMACEUTICALS INC.] | 21 | Current NDC, Legacy NDC, 1 package rows | 20250216_1e6bea44-57d6-4bac-9328-46e1ee59f83b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63090-340-30 | 63090034030 | 30 CAPSULE in 1 BOTTLE, PLASTIC (63090-340-30) | 30 capsule | 2018-06-28 | 0000-00-00 | No | No | Current |